Lixte Biotechnology Inc. (LIXT) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lixte Biotechnology Inc.

    NASDAQ: LIXT · Real-Time Price · USD
    6.00
    0.73 (13.85%)
    At close: Sep 12, 2025, 3:59 PM
    6.12
    1.92%
    After-hours: Sep 12, 2025, 07:36 PM EDT

    Lixte Biotechnology Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -3.59M -5.09M -6.31M -6.73M
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 418.42K 773.2K 1.55M 2.6M
    Other Working Capital
    		 3.01K 94.54K 150.96K -49.11K
    Other Non-Cash Items
    		 n/a n/a n/a n/a
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 3.01K 20.56K 154.76K -13.44K
    Operating Cash Flow
    		 -3.16M -4.29M -4.61M -4.14M
    Capital Expenditures
    		 n/a 5.00 -3 -5
    Cash Acquisitions
    		 n/a n/a 5.14M n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a 3.14M n/a n/a
    Other Investing Acitivies
    		 n/a -3.14M n/a n/a
    Investing Cash Flow
    		 n/a n/a 5.14M n/a
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 6.32K n/a 207.63K
    Financial Cash Flow
    		 n/a 3.14M 5.14M 3.9M
    Net Cash Flow
    		 -3.16M -1.15M 529.65K -245.52K
    Free Cash Flow
    		 -3.16M -4.29M -4.61M -4.14M

    Add to Watchlist